Newsfeeds - Spark Newswire

2 minute read

News

Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement With Verity Pharmaceuticals To Expand Support For Sancuso

Today, 6:09 AM

Specialty pharmaceutical company Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it has entered into a national co-promotion agreement with Verity Pharmaceuticals International Ltd. to

CPIX

48 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 6:09 AM

During Thursday, 849 stocks hit new 52-week lows.

AADI

1 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 6:09 AM

ABIO

1 minute read

Cumberland Q4 EPS $(0.13) Down From $0.01 YoY, Sales $8.32M Miss $9.19M Estimate

By Bill Haddad

Today, 6:09 AM

Cumberland (NASDAQ:CPIX) reported quarterly losses of $(0.13) per share. This is a 1400 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $8.32

CPIX

6 minute read

Earnings Scheduled For March 8, 2022

By Benzinga Insights

Today, 6:09 AM

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million.

ABM

3 minute read

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg

By Shanthi Rexaline

Today, 6:09 AM

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.

ACHV

2 minute read

Cumberland Pharmaceuticals Acquires SANCUSO From Kyowa Kirin; Terms Include $13.5M Payment To Kyowa Kirin Upon Closing, Up To $3.5M In Milestones And Tired Royalties Up To 10%

By Bill Haddad

Today, 6:09 AM

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company, announced today that it has entered into and closed on a definitive agreement to acquire the FDA-approved oncology-supportive

CPIX